ArticleBritish journal of pharmacology2009

Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products.

Chun Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.